🇺🇸 Lactobacillus Fermentum in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Gastroenteritis — 1 report (12.5%)
2. Immunodeficiency — 1 report (12.5%)
3. Intestinal Obstruction — 1 report (12.5%)
4. Meningitis — 1 report (12.5%)
5. Neutropenia — 1 report (12.5%)
6. Off Label Use — 1 report (12.5%)
7. Pneumonia — 1 report (12.5%)
8. Vomiting — 1 report (12.5%)

Source database →

Frequently asked questions

Is Lactobacillus Fermentum approved in United States?

Lactobacillus Fermentum does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Lactobacillus Fermentum in United States?

HEM Pharma Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.